Nano-Thin Polyzene-F Polymer

Designed to be thrombo-resistant.

Introducing a new category of stent that combines a unique cobalt chromium stent platform with the cutting-edge Polyzene-F (PzF) nano-thin polymer designed to be highly deliverable and biocompatible.

This next generation PzF nanocoating is the result of years of rigorous scientific research and German-engineering.

The COBRA PzF NanoCoated Stent is the first nanocoated stent ever to be evaluated in clinical trials in the United States.*

About COBRA PzF Stent

SCAI 2017

COBRA PzF NanoCoated Stent Symposium @ SCAI 2017

May 10 – 13, 2017
New Orleans, LA

Hilton New Orleans Riverside
2 Poydras Street, New Orleans, LA 70130


Optimizing PCI in high-bleeding risk patients with COBRA PzF NanoCoated Stent (NCS)*

Friday, May 12, 2017
6:30am – Check-In & Breakfast
6:45am-7:45am – Program
Room: TBD

Register Today

*COBRA PzF NanoCoated stent is an investigational device in the US and currently being studied in clinical trials with 1-month and only 2 week DAPT duration for patients at high risk of bleeding.

CeloNova’s microsphere interventional radiology product line has been acquired by Boston Scientific. Click here to read the press release.

I acknowledge that I am entering CeloNova’s international website.

Yes ​No